المؤلفون: Bakdash, G, Buschow, SI, Gorris, MAJ, Halilovic, A, Hato, SV, Skold, AE, Schreibelt, G, Sittig, SP, Torensma, R, Duiveman-de Boer, T, Schroder, C, Smits, EL, Figdor, CG, de Vries, IJM

المصدر: Cancer research. 76(15):4332-4346

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:134106099

المؤلفون: van Beek, JJP, Wimmers, F, Hato, SV, de Vries, IJM, Skold, AE

المصدر: Critical reviews in immunology. 34(6):517-536

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130510702

المؤلفون: Van Wigcheren, GF, De Haas, N, Mulder, TA, Horrevorts, SK, Bloemendal, M, Hins-Debree, S, Mao, YM, Kiessling, R, van Herpen, CML, Florez-Grau, G, Hato, SV, De Vries, IJM

المصدر: Oncoimmunology. 10(1):1935557

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146960330

المؤلفون: RICOUR, Céline, DELHAYE, S, HATO, SV, OLENYIK, TD, MICHEL, B, van KUPPEVELD, FJ, GUSTIN, Dominique, MICHIELS, T

المصدر: Journal of General Virology, 90, 177-186 (2009)

مصطلحات موضوعية: Life sciences, Biochemistry, biophysics & molecular biology, Sciences du vivant, Biochimie, biophysique & biologie moléculaire

Relation: urn:issn:0022-1317; urn:issn:1465-2099

URL الوصول: https://orbi.uliege.be/handle/2268/144341

المؤلفون: Di Blasio S; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Tumour-Host Interaction Lab, The Francis Crick Institute, London, UK., van Wigcheren GF; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Becker A; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Duffelen A; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Gorris M; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Verrijp K; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Stefanini I; Division of Biomedical Sciences, The University of Warwick, Coventry, UK.; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy., Bakker GJ; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bloemendal M; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Halilovic A; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Vasaturo A; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bakdash G; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Hato SV; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Schalkwijk J; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries IJM; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Textor JC; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van den Bogaard EH; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., Tazzari M; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. carl.figdor@radboudumc.nl.; Immunotherapy-Cell Therapy and Biobank Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. carl.figdor@radboudumc.nl., Figdor CG; Department of Tumour Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. marcella.tazzari@irst.emr.it.; Oncode Institute, Utrecht, The Netherlands. marcella.tazzari@irst.emr.it.

المصدر: Nature communications [Nat Commun] 2020 Jun 02; Vol. 11 (1), pp. 2749. Date of Electronic Publication: 2020 Jun 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Cell Plasticity/*physiology , Dendritic Cells/*metabolism , Melanoma/*metabolism , Tumor Microenvironment/*physiology, Cell Communication ; Cell Survival ; Coculture Techniques ; Fibroblasts/pathology ; Humans ; Keratinocytes/pathology ; Melanoma/immunology ; Melanoma/pathology ; Skin/pathology ; Skin Neoplasms/immunology ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology ; Tumor Microenvironment/immunology ; Melanoma, Cutaneous Malignant

المؤلفون: Boudewijns S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Bloemendal M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Haas N; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Aarntzen EHJG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Lesterhuis WJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; School of Biomedical Sciences, University of Western Australia, Crawley, Australia., Gorris MAJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Croockewit A; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Woude LL; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., Welzen M; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., de Goede A; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., Hato SV; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Punt CJA; Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Vries IJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Mar; Vol. 69 (3), pp. 477-488. Date of Electronic Publication: 2020 Jan 24.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*therapeutic use , Cisplatin/*therapeutic use , Dendritic Cells/*immunology , Melanoma/*drug therapy, Adolescent ; Adult ; Aged ; Cancer Vaccines/pharmacology ; Cisplatin/pharmacology ; Female ; Humans ; Male ; Melanoma/pathology ; Middle Aged ; Monocytes/immunology ; Neoplasm Staging ; Prospective Studies ; Vaccination ; Young Adult

المؤلفون: de Haas N; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., de Koning C; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., di Blasio S; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Flórez-Grau G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Hato SV; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.

المصدر: Journal of immunology research [J Immunol Res] 2019 Jun 11; Vol. 2019, pp. 7458238. Date of Electronic Publication: 2019 Jun 11 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101627166 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-7156 (Electronic) Linking ISSN: 23147156 NLM ISO Abbreviation: J Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Dendritic Cells/*drug effects , Dendritic Cells/*metabolism , Platinum/*pharmacology , STAT Transcription Factors/*metabolism, Biomarkers ; Cell Differentiation ; Dendritic Cells/cytology ; Dendritic Cells/immunology ; Gene Expression ; Humans ; Immunophenotyping ; Phosphorylation ; STAT Transcription Factors/genetics ; Signal Transduction

المؤلفون: Buschow SI; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Gastroenterology and Hepatology, Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands., Ramazzotti M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Reinieren-Beeren IMJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Heinzerling LM; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany., Westdorp H; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Stefanini I; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Beltrame L; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Hato SV; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Ellebaek E; CCIT, Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Gross S; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany., Nguyen VA; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Weinlich G; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Ragoussis J; Genomics Group, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.; Current address: McGill University and Genome Quebec Innovation Centre, McGill University, Quebec, Canada., Baban D; Genomics Group, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Schuler-Thurner B; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany., Svane IM; CCIT, Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Romani N; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Austyn JM; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK., De Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Schuler G; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany., Cavalieri D; Department of Biology, University of Florence, Firenze, Italy., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: Oncotarget [Oncotarget] 2017 Jun 27; Vol. 8 (40), pp. 67439-67456. Date of Electronic Publication: 2017 Jun 27 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

المؤلفون: Hato SV; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Takahashi S; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., Pen AE; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Halilovic A; Department of Pathology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Bol KF; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Vasaturo A; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Inoue Y; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., de Haas N; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Verweij D; Department of Pathology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Van Herpen CML; Department of Medical Oncology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Kaanders JH; Department of Radiation Oncology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., van Krieken JHJM; Department of Pathology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Van Laarhoven HWM; Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Hooijer GKJ; Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Punt CJA; Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Asai A; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., de Vries IJM; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Lesterhuis WJ; Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.; Current address: University of Western Australia, School of Medicine and Pharmacology, Perth, Australia.

المصدر: Oncotarget [Oncotarget] 2017 May 07; Vol. 8 (33), pp. 54434-54443. Date of Electronic Publication: 2017 May 07 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

المؤلفون: Di Blasio S; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Wortel IM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., van Bladel DA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., de Vries LE; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Worah K; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., de Haas N; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Buschow SI; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Hato SV; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2016 Aug 03; Vol. 5 (8), pp. e1192739. Date of Electronic Publication: 2016 Aug 03 (Print Publication: 2016).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE